Medtronic ( NYSE: MDT ) stock closed positively on Tuesday, snapping a six-day slump during which it lost 4.84%. Shares of the medical device maker closed +0.
34% at $77.38, above its 52-week low of $69.84.
The stock has lost 10.40% in value in the last 12 months. Medtronic has closed in the green for seven trading days in June so far.
During the month of May, it closed positively for 16 out of 22 sessions. Looking at Seeking Alpha's Quant Ratings , MDT has a Hold rating with a score of 3.14 out of 5.
The company received an A+ for profitability and a D- for growth prospects. The stock also got a D+ for its valuation, similar to its rating six months ago. Turning to the Wall Street community , 16 out of 33 analysts in the last 90 days gave the stock a Buy or higher recommendation, with 14 recommending a Hold and 3 recommending a Sell or lower.
Seeking Alpha analysts are optimistic and see the stock as a Buy. Earlier last week, Medtronic reiterated its first quarter and fiscal year 2025 outlook after its CFO Karen Parkhill decided to leave the company to become CFO at HP Inc. ( HPQ ).
"MDT stock could be nearly 20% undervalued from the current share price," read a report by Kody's Dividends. "The med tech company could be positioned for 45%+ cumulative total returns through fiscal year 2027," it added. Another report by Seeking Alpha analyst Sensor Unlimited wrote , "Compared to many of its peers, MDT has a heavy reliance on mature medical device markets, which tend to have slo.
